Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach
Nutrients · 17.11.2025 · 17 (22) · 3595
DOI: 10.3390/nu17223595 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 17.11.2025. Verfasst von Ioanna Aggeletopoulou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Diet. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Irritable Bowel Syndrome (IBS) is a prevalent and heterogeneous functional gastrointestinal disorder with a complex and multifactorial pathophysiology. Traditional treatment approaches have focused on symptom relief, often overlooking the underlying biological mechanisms driving the disease. Τhis review summarizes the current evidence linking core pathophysiological pathways of IBS with mechanism- and diet- based therapeutic strategies to guide personalized treatment. Serotonergic signaling, microbial dysbiosis, immune activation, epithelial barrier dysfunction, and bile acid malabsorption interact to shape the diverse phenotypes of IBS, contributing to altered motility, visceral hypersensitivity, and gut-brain axis dysregulation. Increasing evidence supports that targeted dietary and biological interventions including low-FODMAP and Mediterranean low-FODMAP diets, targeted use of probiotics and psychobiotics, and vitamin D supplementation can modulate microbial composition, reduce luminal irritants, support barrier integrity, and attenuate immune system activation. Similarly, pharmacologic therapies including serotonergic receptor modulators, bile acid sequestrants and neuroimmune agents act on specific mechanistic pathways, reflecting a shift from symptom-based to mechanism-driven management. Collectively, these findings highlight that integrating dietary, microbial, neuroimmune, and serotonergic modulation within a unified therapeutic framework can support a more rational and individualized approach to IBS management and long term symptom control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece.
- Department of Psychiatry, University of Patras, 26504 Patras, Greece.
- Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London W2 1NY, UK.
ORCID-Profile: Ioanna Aggeletopoulou, Maria Kalafateli, Christos Triantos
Zitieren
APA
Aggeletopoulou, I., Karaivazoglou, K., Kalafateli, M., & Triantos, C. (2025). Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach. Nutrients, 17(22), 3595. https://doi.org/10.3390/nu17223595
Vancouver
Aggeletopoulou I, Karaivazoglou K, Kalafateli M, Triantos C. Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach. Nutrients. 2025;17(22):3595. doi:10.3390/nu17223595
BibTeX
@article{Aggeletopoulou2025,
author = {Aggeletopoulou, Ioanna and Karaivazoglou, Katerina and Kalafateli, Maria and Triantos, Christos},
title = {Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {22},
pages = {3595},
doi = {10.3390/nu17223595}
}
EUVIMED